SEC Form 4 · accession 0001179110-15-002170
Theravance Biopharma, Inc. · TBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett K Haumann
Officer — SVP, Clinical Development
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 5, 2015 | A | 135,000 | $0.00 | A | 140,714 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 5,714 shares acquired in a pro rata distribution by Theravance, Inc.